NCT02949960View on ClinicalTrials.gov

DMT210 Topical Gel in the Treatment of Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

July 14, 2017

Study Completion Date

July 14, 2017

Conditions
Atopic Dermatitis
Interventions
DRUG

DMT210 Topical Gel

DMT210 Topical Aqueous Gel 5% applied twice daily

DRUG

Vehicle Control

Topical Vehicle Gel applied twice daily

Trial Locations (2)

23502

Dermata Investigational Site, Norfolk

77056

Dermata Investigational Site, Houston

Sponsors
All Listed Sponsors
lead

Dermata Therapeutics

INDUSTRY

NCT02949960 - DMT210 Topical Gel in the Treatment of Atopic Dermatitis | Biotech Hunter | Biotech Hunter